Loading...
Novel Glutamatergic Treatments for Severe Mood Disorders
All currently approved antidepressant medications for major depressive disorder (MDD) and bipolar disorder act primarily on the monoaminergic system and have varying affinities for serotonergic, norepinephrine-ergic, and/or dopaminergic receptors. Unfortunately, these drugs are only effective in app...
Saved in:
| Published in: | Curr Behav Neurosci Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4725605/ https://ncbi.nlm.nih.gov/pubmed/26824031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40473-015-0050-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|